On cancer-fighting nanorobots

Abstract

There have recently been two major developments and advances in this field, namely1 the construction of an autonomous DNA nanorobot as an intelligent drug delivery and therapeutic system that responds to molecular triggers in vivo and2 the successful programming of autonomous nanorobots to shrink tumors by cutting-off their blood supply (an antiangiogenic approach, see Fymat).3 The structures are built from DNA that can self-fold in all sorts of shapes and sizes.